Now Available: Innovators Under 35 2013 See The 2013 List »

Benjamin G. Davis, 33
Manipulates biological sugars for more precise drug delivery
Glycoform
Researchers have long known that proteins- pivotal players in everything from embryonic development to Alzheimer’s disease- often have sugars attached to them. But understanding precisely how those sugars influence the proteins’ functions was exceedingly difficult until the arrival of novel chemical reactions devised by University of Toronto postdoc Benjamin Davis. The reactions enabled Davis to add or substitute sugars on proteins with Lego-like ease- solving a problem that had stymied researchers for decades. Manipulating sugars could make it easier not only to systematically study the basic biology of proteins, but also to engineer them as drugs. Indeed, Davis is exploiting his techniques to create a drug delivery system in which different sugars direct protein-based drugs to target cells or organs. In November 2002, Davis who is now a lecturer at the University of Oxford, cofounded Glycoform in England to commercialize this and other work; within a week he obtained $2 million in venture funding. The company is now conducting trials of the drug delivery system and developing new sugar attachment techniques.
2003 TR35 Winners
Guillermo Ameer
Synthesized "biorubbers" that could replace damaged heart and lung tissue and rebuild blood vessels
Helene Andersson
Produces portable, inexpensive, microprocessor-size labs for research and industry
Sangeeta Bhatia
Uses microchip-manufacturing tools to build artificial livers
Alexis Borisy
Believes that combining different drugs could yield better ways to fight disease
Eugene Chan
Aims to speed genome sequencing with a machine that reads DNA letter by letter
Bassil Dahiyat
Designs proteins from scratch to create new medicine
Benjamin G. Davis
Manipulates biological sugars for more precise drug delivery
Christophe Echeverri
Develops fast, automated processes for figuring out genes functions
Michael E. Gertner
Set out to improve the tiny devices that keep once blocked arteries open
Jay Groves
Patented a lab-on-a-chip to investigate call proteins that cause diseases
Justin Hanes
Creates systems for delivering drugs to where theyre needed in the body
Andre Koltermann
Speeds protein evolution to improve detergents, medicines, and foods
Erin Lavik
Helped paralyzed rats walk again and aims to do the same for people
Xiangjun Liu
Maps gene variations that could warn of future disease
Anthony Lowman
Packs insulin into gel pills that could replace injections for diabetes patients
Gavin Macbeath
Unravels complex biological systems in his search for new drugs
Nimmi Ramanujam
Uses light to help make diagnosing breast cancer and cervical cancer faster, more accurate and less invasive
Shuvo Roy
Builds tiny machines that can warn of impending heart attack and monitor healing after surgery
Ram Samudrala
Wrote algorithms that can predict the functions of proteins from the sequence of a genome
Christophe Schilling
Transforms microbes into fine-tuned manufacturing machines
Mark Schnitzer
Sheds light on the functioning of individual brain cells
Mijail Serruya
Connects brains directly to computers int he hope of helping paralyzed people communicate and control robotic aids
Micah Siegel
Transforms research from universities and national labs into successful startups
Giovanni Traverso
Came up with a noninvasive alternative to colonoscopy
Rita Vanbever
Wants to make treating diabetes as easy as breathing
Ron Weiss
Programs living cells to sense toxins ot create replacement tissues
Jennifer West
Synthesizes blood vessels that could reduce the trauma of heart surgery
Daphne Zohar
Spots promising biotech work and helps build new companies to commercialize it